论文部分内容阅读
目的:分析6项血清性激素在女性不孕症患者中检测价值。方法:选取女性不孕症患者100例作为实验组,选取同时期100例健康体检者作为对照组,检测并记录两组孕酮(PRGE)、黄体生成素(LH)、睾酮(T)、促卵泡生成素(FSH)、雌二醇(E2)、泌乳素(PRL),比较两组差异。结果:比较两组LH、FSH、PRL,差异具有统计意义[(24.06±12.06)mIU/mlVS(8.99±2.42)mIU/ml,(22.21±13.77)mIU/mlVS(8.91±2.79)mIU/ml,(26.74±19.57)ng/mlVS(10.23±3.45)ng/ml,P<0.05]。结论:不孕症患者体内内分泌情况可通过血清性激素LH、FSH、PRL反应,血清性激素水平变化可为女性不孕症的诊断及治疗提供临床依据。
Objective: To analyze the detection value of six serum hormones in female infertility patients. Methods: One hundred female infertility patients were selected as the experimental group. 100 healthy subjects were selected as the control group. The levels of progesterone (PRGE), luteinizing hormone (LH) and testosterone (T) were detected and recorded Follicle-stimulating hormone (FSH), estradiol (E2) and prolactin (PRL) were compared between the two groups. Results: The differences of LH, FSH and PRL between the two groups were statistically significant ([(24.06 ± 12.06) mIU / ml vs 8.99 ± 2.42 mIU / ml and (22.21 ± 13.77) mIU / ml vs 8.91 ± 2.79 mIU / (26.74 ± 19.57) ng / mlVS (10.23 ± 3.45) ng / ml, P <0.05]. Conclusion: The endocrine status of infertility patients may provide clinical evidence for the diagnosis and treatment of female infertility through the changes of serum sex hormones LH, FSH, PRL and serum sex hormone levels.